Zero ad trackers.We never sell your data.Healthcare professional?Clinician Resources
Home/Rare Diseases/Usher Syndrome

Neurological & Neuromuscular

Usher Syndrome (USH1) Clinical Trials and Treatments

Also called Usher syndrome type 1, USH1, Usher syndrome type 2, USH2, Usher syndrome type 3, USH3, Retinitis pigmentosa with hearing loss

Usher syndrome is a genetic condition that combines progressive hearing loss with progressive vision loss from retinitis pigmentosa. It represents almost half of all genetic deaf-blindness cases. The condition results from mutations in genes responsible for maintaining the health of cells in the inner ear and retina.

In plain words, Usher syndrome is an inherited condition where hearing loss often starts at birth and vision loss slowly gets worse over time. Gene changes harm cells in the inner ear and the light-sensing layer at the back of the eye, and some types also affect balance.

Get an email when new Usher Syndrome trials open or the FDA decides. Get alerts

Usher Syndrome

Where treatments stand, from ClinicalTrials.gov and FDA labels

Also 5 studies with no phase, like observational studies.

FDA review0

No decision pending. FDA calendar

FDA-approved medicines0

No medicine's current FDA label names Usher Syndrome yet.

Usher Syndrome has no FDA-approved medicines, 9 open or active clinical trials (7 recruiting), and no pending FDA decision.

Labels checked October 21, 2026.Download the data

Each date is the day a change was posted. Open an item to see where things stand now.

More about Usher Syndrome

Three types exist based on genetic cause and symptom severity. Type 1 presents with congenital profound hearing loss, balance problems, and vision loss beginning in late childhood. Type 2 involves moderate congenital hearing loss without balance problems, with vision loss appearing in the second or third decade. Type 3 is rarer, with later onset of both hearing and vision loss.

Keep reading about Usher Syndrome

At least 9 genes have been identified, with MYO7A and USH2A accounting for the majority of cases. Currently, management focuses on hearing aids, cochlear implants, and vision rehabilitation, though emerging gene therapies offer promise for future treatment.

What are the symptoms of Usher Syndrome?

These are common symptoms of Usher Syndrome, and how strong they are varies from person to person.

  • Hearing loss present from birth in types 1 and 2, or starting in childhood in type 3, ranging from moderate to profound
  • Progressive vision loss beginning in childhood or adolescence due to retinitis pigmentosa
  • Balance and coordination problems, particularly in type 1
  • Tunnel vision and eventual blindness as vision loss progresses
  • Difficulty seeing in dark environments (night blindness)
  • Delayed walking and coordination challenges in infants with type 1

Who gets Usher Syndrome?

Usher syndrome follows autosomal recessive inheritance, affecting males and females equally across all ethnic groups. Type 1 is more common in Ashkenazi Jewish and French-Acadian populations. Type 3 is most common in Finnish and Ashkenazi Jewish populations. Symptoms begin at birth or in early childhood and progress throughout life.

Next steps: find trials you might fitsee what is being testedget help payingget alerts

Which new Usher Syndrome medicines are in trials?

Investigational medicines Trial Friend tracks for Usher Syndrome, with trial results, safety findings and where each one stands.

How to get help paying for Usher Syndrome treatment

Charity funds and drugmaker programs for Usher Syndrome, checked at the source.

Which insurance do you have? Pick one to see what fits. Tap it again to clear.
Your insurance
Charity funds

No charity fund for this condition is open right now. Funds reopen when they receive new donations; the foundations let you sign up to be told when one opens.

Status as each foundation showed it on November 16, 2026.

Open the full patient assistance finder →

Side effects people have reported to the FDA

Side effects people have reported to the FDA

Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.

Loading side effect data...

Diagnosis and genetic testing

Genetic testing for Usher Syndrome

Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.

Finding labs...

Trusted Usher Syndrome resources

Reputable organizations and medical references for learning more about Usher Syndrome, including disease registries, foundation resources, and clinical guidelines.

Active clinical trials for Usher Syndrome

Use this Usher Syndrome clinical trial finder to see the 7 studies recruiting patients and 2 not yet recruiting in the United States and worldwide, with eligibility criteria in plain English. Of these, 4 test a treatment and 5 are observational studies or registries; each card says which. Every trial comes from ClinicalTrials.gov.

Jump to the trial list, the site map or the pipeline timeline.

Note: Trial recruitment statuses on ClinicalTrials.gov may not immediately reflect recent FDA decisions, sponsor announcements, or enrollment changes. Always confirm a trial's current status directly with the study coordinator before making plans.

9 active trials worldwide
Filter:
Sort:
RecruitingTreatment trialPhase 1/2Recently updatedNCT06789445

A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)

Intervention: OpCT-001, OpCT-001

Sponsor: BlueRock Therapeutics · Bayer

Study OpCT-001-101 is a Phase 1/2a first-in-human, multisite, 2-part interventional study to evaluate the safety, tolerability, and the effect on clinical outcomes of OpCT-001 in approximately 54 adults with primary photoreceptor (PR) disease. Phase 1 focuses on safety and featur...

Ages 18 Years+
Started Mar 2025Updated yesterdayEst. Oct 2029 (~2y 11m)
RecruitingTreatment trialPhase 3Recently updatedNCT07710196

A 24-Month Trial of NPI-001 for the Preservation of Photoreceptors in Retinitis Pigmentosa Associated With Usher Syndrome

Intervention: Placebo, NPI-001

Sponsor: Nacuity Pharmaceuticals, Inc.

The goal of this clinical trial is to learn if NPI-001 works to prevent progression of retinitis pigmentosa in adults diagnosed with Usher syndrome. It will also provide information about the safety of NPI-001. The main questions it aims to answer are:

Ages 18 Years+1 location
Started Oct 2026Updated 1 week agoEst. Apr 2029 (~2y 5m)
Not yet recruitingTreatment trialPhase 2Recently updatedNCT07796646

Study to Evaluate the Long-Term Safety of Ultevursen in Participants With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene

Intervention: No intervention, will not receive any active study intervention, Intravitreal Injection of Ultevursen

Sponsor: Laboratoires Thea · Sepul Bio

The purpose of this Phase 2 Open-label study is to evaluate the long-term safety and tolerability of Ultevursen administered via intravitreal injection (IVT) in participants with Retinitis Pigmentosa due to mutations in exon 13 of the USH2A gene. This is a multicenter study which...

Ages 8 Years+
Expected to start Oct 2026Updated 2 months agoEst. Feb 2030 (~3y 3m)
Not yet recruitingTreatment trialPhase 3Updated a few months agoNCT07290530

24-Month Trial of NPI-001 for the Preservation of Photoreceptors in Retinitis Pigmentosa Associated With Usher Syndrome

Intervention: N-acetylcysteine amide, Placebo

Sponsor: Nacuity Pharmaceuticals, Inc.

The goal of this clinical trial is to learn if NPI-001 works to prevent progression of retinitis pigmentosa in adults diagnosed with Usher syndrome. It will also provide information about the safety of NPI-001. The main questions it aims to answer are:

Ages 18 Years+
Expected to start Dec 2026Updated 4 months agoEst. Jul 2029 (~2y 8m)
RecruitingPatient registry covering many conditionsNo updates in a whileNCT02435940

Inherited Retinal Degenerative Disease Registry

Sponsor: Foundation Fighting Blindness

The My Retina Tracker® Registry is sponsored by the Foundation Fighting Blindness and is for people affected by one of the rare inherited retinal degenerative diseases studied by the Foundation. org. Affected individuals who register are guided to create a profile that captures t...

Ages not specified1 location
Started Jun 2014Updated 6 months agoEst. Jun 2037 (~10y 7m)
Find Usher Syndrome trials near you, ranked by distance →
Active trial locations8 cities in the US
A study site. Select it to see its trials and get directions. Several sites close together. Select the number to zoom in.

Trial Pipeline

Jan 2021 to Nov 2031
2021
2023
2025
2027
2029
2031
now
Phase 1
Phase 2
Phase 3
Observational
RecruitingNot yet recruitingDelayed startTodayHover a bar for trial details

Read more about Usher Syndrome trials

Need help understanding these trials?
Answers with sources, in plain English
Start withor ask
Run an Usher Syndrome foundation or patient group?
You can put this live trial list on your own website. It updates itself, and it's free.
Get the embed code →

Data from ClinicalTrials.gov, U.S. National Library of Medicine.
Always talk to your doctor before considering a clinical trial.

Usher Syndrome patient communities

Facebook groups, Reddit communities and YouTube channels where Usher Syndrome patients, caregivers and advocacy groups talk.

Companies developing Usher Syndrome treatments

Drugmakers that list Usher Syndrome in their rare disease portfolio, 2 in all.

Questions people ask about Usher Syndrome